Viral Metagenomics
What Is Viral Metagenomics?
Viral metagenomics is an untargeted sequencing approach that enables researchers to detect, identify, and characterize viral communities directly from environmental, clinical, or host-associated samples—without prior knowledge of the viruses present. Unlike PCR-based assays, which require specific primers, viral metagenomics uses shotgun next-generation sequencing (NGS) to capture all viral genetic material, including DNA and RNA viruses, known and novel.
This unbiased method is essential for viral discovery, surveillance, and ecology studies, as it can identify:
-
Novel viruses with no reference genome,
-
Low-abundance viral populations, and
-
Viral dynamics across complex microbial ecosystems.
At AUGenomics, our viral metagenomics workflows integrate optimized nucleic acid extraction, host nucleic acid depletion, and deep sequencing, followed by comprehensive bioinformatics to assemble viral genomes and annotate viral diversity with high accuracy.
Advantages of Viral Metagenomics
01
Unbiased Detection: Captures both known and novel viruses without the need for prior targets.
02
Whole-Virome Profiling: Provides a comprehensive snapshot of viral communities in a single assay.
03
Broad Sample Compatibility: Supports environmental, clinical, agricultural, and industrial sample types.
04
Low Abundance Sensitivity: Detects viral sequences even when present at very low levels.
05
RNA and DNA Virus Coverage: Simultaneous analysis of both RNA and DNA viruses.
06
Advanced Bioinformatics: Includes de novo assembly, taxonomic classification, and functional annotation.
07
Customizable Depth: Sequencing depth adjusted for discovery studies or high-resolution viral population analysis.
08
Rapid Outbreak Response: Supports viral detection in emerging disease surveillance.
09
Cross-Species Applications: Effective for human, animal, and environmental virology research.
Viral metagenomics is transforming how researchers understand viral diversity, evolution, and interactions with hosts and environments. Common applications include:
-
Viral Discovery: Identifying previously unknown viruses in clinical, environmental, or animal samples.
-
Disease Outbreak Investigation: Detecting emerging pathogens during outbreaks (e.g., novel respiratory or zoonotic viruses).
-
Viral Ecology: Mapping viral diversity and population dynamics in ecosystems such as oceans, soils, and wastewater.
-
Clinical Virology: Diagnosing complex or unexplained infections where targeted tests fail.
-
Agricultural Research: Studying plant and livestock viruses affecting yield and health.
-
Phage Therapy Development: Characterizing bacteriophages for therapeutic or biocontrol applications.
-
Viral Evolution Studies: Tracking mutation rates, recombination, and cross-species transmission events.
-
Biotechnology: Leveraging viral enzymes or structures for industrial and research applications.
What is Viral Metagenomics Used For?
Viral Metagenomics with AUGenomics
Sample Submission
Minimum 10–20 ng of cfDNA isolated from plasma or other biofluids. Use EDTA or Streck tubes for blood collection. Samples must be frozen and shipped overnight on dry ice.
Please refer to our Shipping Guidelines for project-specific guidance.
Turnaround Time
Typical turnaround for viral cfDNA detection and typing is 10–12 business days from sample receipt. Expedited options are available depending on project scope and sequencing depth.
Frequently Asked Questions (FAQs)
Q: What types of viruses can be detected with this method?
A: Our panel can detect a broad range of DNA viruses, including CMV, EBV, HPV, HBV, and more. Custom panels are also available.
Q: Is this method quantitative or qualitative?
A: Both. It can determine presence/absence of specific viruses and provide estimates of viral load based on read depth.
Q: How does viral metagenomics differ from targeted PCR or qPCR tests?
A: PCR assays detect only known viruses with specific primers, while viral metagenomics sequences all viral nucleic acids in a sample, enabling unbiased detection of both known and novel viruses.
Q: Can this method detect novel viruses with no reference genome?
A: Yes. Using de novo assembly and similarity-based classification, our pipeline can identify unknown viruses based on sequence homology and structural features.
Q: What types of samples are compatible?
A: We accept a broad range of samples, including clinical specimens (blood, swabs, CSF), environmental samples (soil, water, wastewater), and agricultural samples (plant tissues, animal swabs).
Q: Does this method quantify viral load?
A: While relative abundance can be inferred, quantitative viral load is best assessed with complementary targeted assays (e.g., qPCR). However, sequencing depth can be adjusted for semi-quantitative insights.
Q: How much input material is required?
A: Input requirements depend on sample type, but our workflows are optimized for low nucleic acid yields typical of viral extractions.
Got more questions? Contact our team and get a free consultation anytime. info@augenomics.com
Glossary of Terms
-
cfDNA: DNA fragments freely circulating in the bloodstream
-
Viral typing: Identifying the specific strain or subtype of a virus
-
CMV/EBV/HPV: Common DNA viruses associated with disease or cancer
-
Transplant monitoring: Using biomarkers to track graft health and infection
